scanX
Home
Kopran

Kopran

349.65
+6.20
(1.81%)
Market Cap (₹ Cr.)
₹1,660
52 Week High
369.70
Book Value
₹102
52 Week Low
185.45
PE Ratio
28.00
PB Ratio
3.38
PE for Sector
38.62
PB for Sector
4.68
ROE
6.20 %
ROCE
26.33 %
Dividend Yield
0.87 %
EPS
₹12.30
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
13.56 %
Net Income Growth
87.11 %
Cash Flow Change
27.16 %
ROE
67.31 %
ROCE
56.54 %
EBITDA Margin (Avg.)
42.89 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
110
45
53
46
44
34
52
47
58
26
32
63
41
29
50
63
61
40
50
56
39
60
50
59
64
32
58
56
67
71
68
69
82
67
104
84
99
52
Expenses
98
39
46
40
39
31
47
39
48
23
29
56
37
28
44
53
52
35
44
46
34
49
38
51
55
29
52
51
58
65
48
62
73
65
90
70
75
44
EBITDA
11
6
7
6
5
3
5
8
10
3
3
8
4
1
6
11
9
4
6
10
5
11
13
8
9
3
7
5
9
7
21
7
9
2
14
13
23
7
Operating Profit %
7 %
9 %
12 %
9 %
12 %
3 %
5 %
14 %
14 %
4 %
5 %
7 %
6 %
-1 %
11 %
15 %
10 %
6 %
8 %
17 %
11 %
15 %
20 %
9 %
11 %
2 %
8 %
6 %
10 %
9 %
11 %
9 %
9 %
1 %
9 %
15 %
17 %
11 %
Depreciation
-0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Interest
4
2
2
2
3
2
2
3
3
2
1
2
2
1
1
1
2
1
1
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
1
Profit Before Tax
8
3
4
3
2
1
2
5
6
0
1
5
1
-1
4
8
6
2
3
8
3
8
11
6
8
1
5
3
7
5
19
5
8
0
13
11
21
6
Tax
0
0
0
0
0
0
0
0
4
0
0
0
1
0
1
2
1
0
1
1
1
1
2
1
1
0
1
1
2
1
1
1
2
0
2
3
5
1
Net Profit
8
3
4
3
2
1
2
5
1
0
1
5
-2
-1
3
7
4
2
2
5
2
6
7
4
6
1
4
2
5
4
18
4
6
0
11
9
15
4
EPS in ₹
1.97
0.62
0.98
0.71
0.45
0.16
0.48
1.05
0.28
0.07
0.13
1.25
-0.36
-0.16
0.64
1.62
0.90
0.33
0.56
1.27
0.42
1.39
1.73
1.00
1.30
0.20
0.87
0.54
1.08
0.79
3.71
0.84
1.14
0.03
2.21
1.77
3.18
0.88
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
275
279
311
300
319
327
324
464
506
511
Fixed Assets
33
35
39
38
42
43
47
46
47
52
Current Assets
193
83
104
92
107
114
111
151
190
188
Capital Work in Progress
0
0
4
8
7
7
3
3
4
5
Investments
0
0
157
157
158
158
159
259
260
261
Other Assets
241
244
110
97
112
119
115
155
195
193
Total Liabilities
89
82
110
95
100
97
77
85
110
94
Current Liabilities
79
58
79
70
75
84
69
76
101
85
Non Current Liabilities
10
25
31
25
25
14
9
9
9
9
Total Equity
186
197
201
206
218
230
247
379
396
417
Reserve & Surplus
136
145
158
162
175
186
204
331
347
369
Share Capital
50
52
43
43
43
43
43
48
48
48
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
0
-0
-0
-0
0
0
-0
1
5
Investing Activities
-10
-4
-9
-2
-4
1
-9
-100
10
-6
Operating Activities
53
19
4
12
12
10
49
-38
17
35
Financing Activities
-43
-15
5
-11
-7
-11
-40
138
-26
-24
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Jan 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
43.78 %
43.78 %
43.78 %
43.78 %
44.25 %
44.25 %
44.25 %
44.25 %
44.30 %
44.30 %
44.49 %
44.49 %
44.49 %
44.49 %
44.49 %
FIIs
0.00 %
0.16 %
0.27 %
0.75 %
0.62 %
0.53 %
0.50 %
0.51 %
0.34 %
0.41 %
0.34 %
0.39 %
0.48 %
0.84 %
0.68 %
DIIs
2.29 %
0.69 %
0.46 %
0.16 %
0.14 %
0.14 %
0.14 %
0.14 %
0.14 %
0.14 %
0.14 %
0.35 %
0.14 %
1.20 %
0.14 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
53.93 %
55.37 %
55.50 %
55.31 %
54.98 %
55.07 %
55.11 %
55.10 %
55.22 %
55.15 %
55.03 %
54.77 %
54.89 %
53.47 %
54.70 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,861.15 4,48,231.75 42.51 49,887.17 12.06 9,648 42.62 67.27
Cipla
1,622.80 1,32,231.02 29.75 26,520.66 14.17 4,155 17.77 53.84
Dr Reddys Laboratories
6,624.90 1,10,988.19 19.94 28,905.40 12.36 5,578 -0.90 45.69
Mankind Pharma
2,699.05 1,09,421.92 55.76 10,615.63 19.57 1,942 9.89 74.75
Zydus Life Science
1,054.05 1,05,835.69 25.39 19,831.50 13.82 3,831 30.78 29.31
Lupin
2,214.00 1,01,003.81 44.63 20,141.50 19.94 1,936 77.69 56.52
Aurobindo Pharma
1,522.00 88,051.92 24.55 29,559.25 17.55 3,169 61.17 46.63
Alkem Laboratories
6,121.45 72,286.01 33.62 12,978.42 9.84 1,811 91.18 50.66
Glenmark Pharmaceuticals
1,689.00 47,904.26 - 12,653.09 6.58 -1,831 96.52 56.39
Biocon
369.50 45,052.52 28.87 15,621.20 35.25 1,298 478.78 55.39

Corporate Action

Technical Indicators

RSI(14)
Neutral
61.41
ATR(14)
Volatile
18.56
STOCH(9,6)
Neutral
35.51
STOCH RSI(14)
Neutral
25.74
MACD(12,26)
Bearish
-2.02
ADX(14)
Strong Trend
42.24
UO(9)
Bearish
42.50
ROC(12)
Uptrend And Accelerating
2.37
WillR(14)
Neutral
-48.17
Bearish
3
Neutral
4
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Candlestick Screeners
Technical Screeners
Fundamental Screeners
Price & Volume Screeners
Intraday Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.